Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

The Contingent Prenatal Screening Test for Down’s Syndrome and Neural Tube Defects in West of Iran

Authors
Faranak Aghaz 1
Seyyedeh Zeinab Ojagh 2
Saber Khanjari 3
Asad Vaisi-Raygani 1
Mozaffar Khazaei 1
Mitra Bakhtiari 1
1 Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Imamreza Clinic, Kermanshah, Iran
3 Gene targeting Lab, John Curtin School of Medical Research, The Australian National University, Kermanshah, Iran
Abstract
Background: The purpose of the study was to evaluate the use of contingent prenatal screening for the detection of Down’s syndrome and neural tube defects (NTDs) in west of Iran. Methods: A prospective study was conducted on 653 pregnant women referred to a medical diagnostic laboratory (Imam Reza Clinic, Kermanshah, Iran) for contingent prenatal screening tests between October 2016 to September 2017. Results: Among 651 women screened in the first trimester, 8 (1.22%) pregnancies were screen-positive for Down’s syndrome. In the second trimester, among 605 women, 25 (4.13%) had a positive result and all of these women voluntarily underwent amniocentesis. Overall, five pregnancies were complicated with chromosomal abnormalities, including five cases of Down’s syndrome. Conclusion: In a nutshell, the contingent prenatal screening tests were found to be useful for estimation of Down’s syndrome as well as NTDs in both young and older mothers in west of Iran. These tests should be performed for pregnant women before an invasive test for Down’s syndrome.
Keywords
Contingent prenatal screening test
down syndrome
Iran
Neural tube defects
  1. Margaret Chan.World Health Organization. 2nd rev. ed. Geneva, Switzerland: Elsiveier; 2015; 267 p.
  2. Askarpour S, Ostadian N, Javaherizadeh H, Chabi S. Omphalocele, gastroschisis: epidemiology, survival, and mortality in Imam Khomeini hospital, Ahvaz-Iran. Pol Przegl Chir. 2012;84(2):82-5.
  3. Sitkin NA, Ozgediz D, Donkor P, Farmer DL. Congenital anomalies in low-and middle-income countries: the unborn child of global surgery. World J Surg. 2015;39(1):36-40.
  4. Goetzinger KR, Shanks AL, Odibo AO, Macones GA, Cahill AG. Advanced maternal age and the risk of major congenital anomalies. Am J Perinatol. 2017;34(3):217-22.
  5. Nicolaides KH. Screening for fetal chromosomal abnormalities: need to change the rules. Ultrasound Obstet Gynecol. 1994;4(5):353-4.
  6. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol. 2007;110(3):687-94.
  7. Wald N, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the serum, uUrine and ultrasound screening study (SURUSS). J Med Screen. 2003;10(2):56-104.
  8. Diamandopoulos K, Green J. Down syndrome: an integrative review. J Neonatal Nurs. 2018;24(5):235-41.
  9. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn. 1997;17(9):821-9.
  10. Wanapirak C, Piyamomgkol W, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Second trimester maternal serum screening for fetal down syndrome: as a sreening test for hemoglobin Bart's disease: a prospective population-based study. Prenat Diagn. 2018;38(9):700-5.
  11. Lee FK, Chen LC, Cheong ML, Chou CY, Tsai MS. First trimester combined test for Down syndrome screening in unselected pregnancies - a report of a 13-year experience. Taiwanese J Obstet Gynecol. 2013;52(4):523-6.
  12. Behzadmehr R, Keikhaie KR, Soltan Pour N. Investigating the attitude of pregnant women on the efficacy of ultrasound in diagnosing pregnancy based on level of education and number of pregnancies in Zabol Amiral-momenin Hospital during 2015-2016. Int J Pharm Life Sci. 2017;8(1);5559-63.
  13. Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, et al. First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening. Cochrane Database Syst Rev. 2017;3:CD012599.
  14. Driscoll DA, Gross SJ; Professional practice guidelines committee. Screening for fetal aneuploidy and neural tube defects. Genet Med. 2009;11(11):818-21.
  15. Mersy E, Smits LJ, van Winden LA, de Die-Smulders CE; South-East Netherlands NIPT Consortium, Paulussen AD, et al. Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012. Hum Reprod Update. 2013;19(4):318-29.
  16. Robinson HP, Fleming JE. A critical evaluation of sonar “crown-rump length” measurements. Br J Obstet Gynaecol. 1975;82(9):702-10.
  17. Christianson A, Howson CP, Modell B. March of dimes: global report on birth defects, the hidden toll of dying and disabled children. 1st ed. USA: March of Dimes Birth Defects Found. 2005. 84 p.
  18. Ali A, Zahad S, Masoumeh A, Azar A. Congenital malformations among live births at Arvand hospital, Ahwaz, Iran- a prospective study. Pakistan J Med Sci. 2008;24(1):33.
  19. Samadirad B, Khamnian Z, Hosseini MB, Dastgiri S. Congenital anomalies and termination of pregnancy in Iran. J Pregnancy. 2012;2012:574513.
  20. Zahed Pasha Y, Vahedi A, Zamani M, Alizadeh-Navaei R, Zahed Pasha E. Prevalence of birth defects in Iran: a systematic review and meta-analysis. Arch Iran Med. 2017;20(6):376-85.
  21. Canfield MA, Mai CT, Wang Y, O’halloran A, Marengo LK, Olney RS, et al. The association between race/ethnicity and major birth defects in the United States, 1999-2007. Am J Public Health. 2014;104(9):e14-23.
  22. Carmichael JB, Liu HP, Janik D, Hallahan TW, Nicolaides KH, Krantz DA. Expanded conventional first trimester screening. Prenat Diagn. 2017;37(8):802-7.
  23. Tu S, Rosenthal M, Wang D, Huang J, Chen Y. Performance of prenatal screening using maternal serum and ultrasound markers for Down syndrome in Chinese women: a systematic review and meta-analysis. BJOG. 2016;123 Suppl 3:12-22.
  24. The selection and use of essential medicines. World Health Organ Tech Rep Ser. 2015;(994):vii-xv, 1-546.
  25. Seyyed Kavoosi E, Younessi S, Farhud DD. Screening of fetal chromosome aneuploidies in the first and second trimester of 125,170 Iranian pregnant women. Iran J Public Health. 2015;44(6):791-6.
  26. Kaewsuksai P, Jitsurong S. Prospective study of the feasibility and effectiveness of a second-trimester quadruple test for Down syndrome in Thailand. Int J Gynecol Obstet. 2017;139(2):217-21.
  27. Phadke SR, Puri RD, Ranganath P. Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario. Indian J Med Res. 2017;146(6):689-99.
Journal of Reproduction & Infertility
Volume 20, Issue 4
Autumn 2019
Pages 244-251